US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Niagen Bioscience

3.22

+0.01000.31%

Volume:154.86K

Turnover:502.78K

Market Cap:256.45M

PE:16.93

High:3.28

Open:3.20

Low:3.20

Close:3.21

52wk High:10.52

52wk Low:2.87

Shares:79.64M

Float Shares:55.82M

Volume Ratio:0.54

T/O Rate:0.28%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.1901

EPS(LYR):0.2000

ROE:21.80%

ROA:5.44%

PB:3.11

PE(LYR):16.10

Loading ...

Overview Company News Filings

Niagen Bioscience Expands Tru Niagen Retail Distribution Through GNC, Sam’s Club Partnership

NAGE Shines Spotlight on New NAD+ Skin‑Aging Trial as Cosmetic Demand Heats Up

Niagen Bioscience to Present at Midwest IDEAS Investor Conference

Is Niagen Bioscience (NAGE) Quietly Recasting Its Brand Around E‑Commerce Scale And Clinical Proof

Simply Wall St.

Niagen Bioscience CFO highlights telehealth as ‘high-expectation growth channel’

Meet Niagen Bioscience: Fly exclusive interview with CFO Ozan Pamir

Bananas, Bread, Bones…Walmart Seals Healthy Aging Deal With Niagen Bioscience

Niagen Bioscience announces Tru Niagen is now available at Walmart

Niagen Bioscience price target lowered to $10 from $12 at Roth Capital

Niagen Bioscience Posts Investor Presentation Focused on NAD+ Science and Healthy-Aging Products

Niagen Bioscience Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Niagen Bioscience Q2 Net Sales Fall, Missing Estimates

Niagen Bioscience Q2 EPS $0.01 Misses $0.02 Estimate, Sales $29.785M Miss $30.690M Estimate

Benzinga Earnings

Niagen Bioscience: Ingredient Business Expected to be Lower than Prior Year as Some Commercial Partners Continue to Face More Competitive Market

THOMSON REUTERS

Niagen Bioscience: Expect Niagen Plus Growth & New Skincare Partnerships to Become Meaningful Contributors Beginning 2027

THOMSON REUTERS

Niagen Bioscience Inc Q2 Net Income USD 963 Thousand

THOMSON REUTERS

Niagen Bioscience Inc Q2 EPS USD 0.01 VS. Ibes Estimate USD 0.01

THOMSON REUTERS

Niagen Bioscience, Inc. Reports Second Quarter 2026 Financial Results

THOMSON REUTERS

Niagen Bioscience Taps Evotec to Advance Preclinical Development of Nb4168 Rare-Disease Candidate

Niagen Bioscience - Plans Ind Application to FDA for Nb4168

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/NAGE/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NAGE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NAGE\",,,,,undefined,":{"symbol":"NAGE","market":"US","secType":"STK","nameCN":"Niagen Bioscience","latestPrice":3.22,"timestamp":1787590270011,"preClose":3.21,"halted":0,"volume":154864,"delay":0,"changeRate":0.00311526479750786,"floatShares":55819168,"shares":79644327,"eps":0.190148,"marketStatus":"Trading","change":0.01,"latestTime":"08-24 12:51:18 EDT","open":3.2,"high":3.28,"low":3.2,"amount":502779.4956272,"amplitude":0.024922,"askPrice":3.23,"askSize":1561,"bidPrice":3.22,"bidSize":1100,"shortable":3,"etf":0,"ttmEps":0.190148,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787601600000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":3.21,"preHourTrading":{"tag":"盘前","latestPrice":3.23,"preClose":3.21,"latestTime":"09:12 EDT","volume":5796,"amount":18438.6681612,"timestamp":1787577120251,"change":0.02,"changeRate":0.006231,"amplitude":0.149533},"postHourTrading":{"tag":"盘后","latestPrice":3.21,"preClose":3.21,"latestTime":"19:57 EDT","volume":5532,"amount":17758.17,"timestamp":1787356668445,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.543733,"impliedVol":1.2191,"impliedVolPercentile":0.5179},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NAGE\",,,,,undefined,":{"symbol":"NAGE","floatShares":55819168,"roa":"5.44%","roe":"21.80%","lyrEps":0.2,"volumeRatio":0.543733,"shares":79644327,"dividePrice":0,"high":3.28,"amplitude":0.024922,"preClose":3.21,"low":3.2,"week52Low":2.87,"pbRate":"3.11","psRate":"1.99","week52High":10.52,"institutionHeld":0,"latestPrice":3.22,"committee":-0.173243,"eps":0.190148,"divideRate":0,"volume":154864,"delay":0,"ttmEps":0.190148,"open":3.2,"prevYearClose":6.36,"prevWeekClose":3.21,"prevMonthClose":3.4,"prevQuarterClose":3.19,"fiveDayClose":3.04,"twentyDayClose":3.23,"sixtyDayClose":3.84},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NAGE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-04","symbol":"NAGE","fiscalQuarterEnding":"2026/06","expectedEps":0.01,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785816000000,"reportTimeType":"post","actualEps":0.01},{"market":"US","date":"2026-05-06","symbol":"NAGE","fiscalQuarterEnding":"2026/03","expectedEps":0.06,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778040000000,"reportTimeType":"post","actualEps":0.07},{"market":"US","date":"2026-03-04","symbol":"NAGE","fiscalQuarterEnding":"2025/12","expectedEps":0.02,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1772600400000,"reportTimeType":"post","actualEps":0.03},{"market":"US","date":"2025-11-04","symbol":"NAGE","fiscalQuarterEnding":"2025/09","expectedEps":0.02,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762232400000,"reportTimeType":"post","actualEps":0.05},{"market":"US","date":"2025-08-06","symbol":"NAGE","fiscalQuarterEnding":"2025/06","expectedEps":0.02,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"post","actualEps":0.04}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NAGE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NAGE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":6,"updateTime":1783396800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NAGE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NAGE","date":"2026-08-21","current":17.118245,"percent":0.148876,"low":13.660897,"twenty":18.243689,"median":26.266446,"eighty":56.409541,"high":80.643552,"avg":35.623148,"sd":19.714561,"marketCap":249772956},"quantilePoints":[{"date":"2025-03-21","current":69.624479,"twenty":69.806742,"median":70.080136,"eighty":70.353531,"marketCap":595289295},{"date":"2025-03-28","current":67.346191,"twenty":68.676711,"median":69.624479,"eighty":70.371757,"marketCap":575809933},{"date":"2025-04-04","current":60.420196,"twenty":62.662031,"median":67.938546,"eighty":69.697384,"marketCap":516592673},{"date":"2025-04-11","current":51.67157,"twenty":54.861173,"median":62.880747,"eighty":69.551574,"marketCap":441791924},{"date":"2025-04-17","current":59.600012,"twenty":54.815607,"median":61.696037,"eighty":69.259953,"marketCap":509580103},{"date":"2025-04-25","current":67.255059,"twenty":55.043436,"median":62.151694,"eighty":68.530901,"marketCap":575030758},{"date":"2025-05-02","current":68.895427,"twenty":55.954751,"median":62.880747,"eighty":69.442216,"marketCap":589055899},{"date":"2025-05-09","current":51.710369,"twenty":55.954751,"median":65.022337,"eighty":70.535794,"marketCap":729374756},{"date":"2025-05-16","current":58.761783,"twenty":54.815607,"median":62.789615,"eighty":69.71561,"marketCap":828834951},{"date":"2025-05-23","current":56.859021,"twenty":55.043436,"median":61.650471,"eighty":69.624479,"marketCap":801996485},{"date":"2025-05-30","current":60.552618,"twenty":55.242319,"median":61.364091,"eighty":69.478669,"marketCap":854094682},{"date":"2025-06-06","current":64.414107,"twenty":55.822209,"median":61.604905,"eighty":69.296406,"marketCap":908560979},{"date":"2025-06-13","current":79.132535,"twenty":56.409541,"median":62.698483,"eighty":70.55402,"marketCap":1116164400},{"date":"2025-06-20","current":77.117845,"twenty":56.623974,"median":63.647427,"eighty":71.912091,"marketCap":1087747202},{"date":"2025-06-27","current":77.341699,"twenty":56.791865,"median":65.523561,"eighty":75.181504,"marketCap":1090904668},{"date":"2025-07-03","current":71.129739,"twenty":57.426855,"median":65.645306,"eighty":75.483707,"marketCap":1003284974},{"date":"2025-07-11","current":65.981088,"twenty":58.471876,"median":66.48476,"eighty":75.192697,"marketCap":930663244},{"date":"2025-07-18","current":57.950311,"twenty":58.471876,"median":65.645306,"eighty":75.114348,"marketCap":817389135},{"date":"2025-07-25","current":51.87826,"twenty":56.758286,"median":65.022337,"eighty":74.190401,"marketCap":731742856},{"date":"2025-08-01","current":52.325969,"twenty":55.224884,"median":64.358143,"eighty":72.732275,"marketCap":738057789},{"date":"2025-08-08","current":43.320593,"twenty":54.318273,"median":62.947882,"eighty":72.15947,"marketCap":768030786},{"date":"2025-08-15","current":43.771379,"twenty":53.985743,"median":62.607352,"eighty":71.628921,"marketCap":776022782},{"date":"2025-08-22","current":44.041851,"twenty":52.415511,"median":61.650471,"eighty":71.37484,"marketCap":780817979},{"date":"2025-08-29","current":44.267244,"twenty":51.68709,"median":61.280145,"eighty":71.129739,"marketCap":784813977},{"date":"2025-09-05","current":42.013311,"twenty":50.71606,"median":60.552618,"eighty":71.083855,"marketCap":744853999},{"date":"2025-09-12","current":43.365671,"twenty":45.745824,"median":60.318517,"eighty":70.845641,"marketCap":768829986},{"date":"2025-09-19","current":45.709762,"twenty":45.222912,"median":59.50888,"eighty":70.6087,"marketCap":810388363},{"date":"2025-09-26","current":42.419019,"twenty":45.024566,"median":58.520194,"eighty":70.371757,"marketCap":752046795},{"date":"2025-10-03","current":33.268051,"twenty":44.46559,"median":56.887002,"eighty":69.697384,"marketCap":589809282},{"date":"2025-10-10","current":34.079467,"twenty":44.02382,"median":56.607185,"eighty":69.623328,"marketCap":604194874},{"date":"2025-10-17","current":33.448366,"twenty":43.66319,"median":55.29204,"eighty":69.583421,"marketCap":593006080},{"date":"2025-10-24","current":33.448366,"twenty":43.41075,"median":54.929521,"eighty":69.405763,"marketCap":593006080},{"date":"2025-10-31","current":32.050928,"twenty":43.28453,"median":54.228731,"eighty":69.187048,"marketCap":568230894},{"date":"2025-11-07","current":25.87441,"twenty":42.455082,"median":54.050915,"eighty":68.822522,"marketCap":528588317},{"date":"2025-11-14","current":27.403352,"twenty":42.022327,"median":53.333314,"eighty":68.390298,"marketCap":559823081},{"date":"2025-11-21","current":26.30565,"twenty":34.151593,"median":52.437896,"eighty":67.731548,"marketCap":537398122},{"date":"2025-11-28","current":26.540872,"twenty":33.854074,"median":52.018169,"eighty":67.346191,"marketCap":542203471},{"date":"2025-12-05","current":26.266446,"twenty":33.628681,"median":51.67157,"eighty":67.255059,"marketCap":536597231},{"date":"2025-12-12","current":25.992021,"twenty":33.448366,"median":50.903505,"eighty":67.255059,"marketCap":530990991},{"date":"2025-12-19","current":25.482373,"twenty":32.772186,"median":49.393282,"eighty":66.988433,"marketCap":520579403},{"date":"2025-12-26","current":25.913613,"twenty":32.474667,"median":46.160548,"eighty":66.182557,"marketCap":529389208},{"date":"2026-01-02","current":24.933522,"twenty":30.002996,"median":45.709762,"eighty":65.94751,"marketCap":509366924},{"date":"2026-01-09","current":25.717595,"twenty":27.520963,"median":45.43929,"eighty":65.757233,"marketCap":525384751},{"date":"2026-01-16","current":24.737504,"twenty":27.019156,"median":45.168818,"eighty":65.594939,"marketCap":505362467},{"date":"2026-01-23","current":24.619893,"twenty":26.909386,"median":44.627874,"eighty":65.546241,"marketCap":502959792},{"date":"2026-01-30","current":23.482987,"twenty":26.540872,"median":44.492638,"eighty":65.122582,"marketCap":479733942},{"date":"2026-02-06","current":20.111473,"twenty":26.282128,"median":44.267244,"eighty":64.478311,"marketCap":410857283},{"date":"2026-02-13","current":19.954658,"twenty":25.944976,"median":44.008043,"eighty":64.391721,"marketCap":407653717},{"date":"2026-02-20","current":19.366604,"twenty":25.843047,"median":43.816458,"eighty":64.134289,"marketCap":395640346},{"date":"2026-02-27","current":20.307491,"twenty":25.623506,"median":43.591065,"eighty":63.1941,"marketCap":414861740},{"date":"2026-03-06","current":23.545172,"twenty":25.529418,"median":43.41075,"eighty":62.988163,"marketCap":409262188},{"date":"2026-03-13","current":22.252496,"twenty":25.411807,"median":43.320593,"eighty":62.862521,"marketCap":386792892},{"date":"2026-03-20","current":21.88316,"twenty":25.058974,"median":43.095199,"eighty":62.753162,"marketCap":380373093},{"date":"2026-03-27","current":20.636651,"twenty":24.761026,"median":42.599334,"eighty":62.487416,"marketCap":358706271},{"date":"2026-04-02","current":20.867486,"twenty":24.619893,"median":42.419019,"eighty":62.007672,"marketCap":362718645},{"date":"2026-04-10","current":20.682818,"twenty":24.345467,"median":42.035851,"eighty":61.696037,"marketCap":359508746},{"date":"2026-04-17","current":21.836993,"twenty":23.875024,"median":35.567063,"eighty":61.604905,"marketCap":379570618},{"date":"2026-04-24","current":21.836993,"twenty":23.545172,"median":34.102007,"eighty":61.448036,"marketCap":379570618},{"date":"2026-05-01","current":21.836993,"twenty":23.175836,"median":33.854074,"eighty":61.280145,"marketCap":379570618},{"date":"2026-05-08","current":18.041368,"twenty":22.760333,"median":33.696298,"eighty":61.168218,"marketCap":336236974},{"date":"2026-05-15","current":16.273169,"twenty":22.34483,"median":33.493445,"eighty":60.552618,"marketCap":303283042},{"date":"2026-05-22","current":16.230344,"twenty":22.248072,"median":33.448366,"eighty":60.552618,"marketCap":302484929},{"date":"2026-05-29","current":16.444465,"twenty":22.012428,"median":33.155355,"eighty":60.44668,"marketCap":306475495},{"date":"2026-06-05","current":14.988445,"twenty":21.873927,"median":32.772186,"eighty":60.257509,"marketCap":279339644},{"date":"2026-06-12","current":14.688676,"twenty":21.735571,"median":32.546792,"eighty":59.723377,"marketCap":273752851},{"date":"2026-06-18","current":14.431731,"twenty":21.468256,"median":32.208703,"eighty":59.545333,"marketCap":268964171},{"date":"2026-06-26","current":14.174786,"twenty":20.98752,"median":28.148222,"eighty":59.396403,"marketCap":264175492},{"date":"2026-07-02","current":14.260435,"twenty":20.867486,"median":27.834592,"eighty":59.097565,"marketCap":265771718},{"date":"2026-07-10","current":14.945621,"twenty":20.636651,"median":27.324945,"eighty":58.568512,"marketCap":278541531},{"date":"2026-07-17","current":14.560203,"twenty":20.370149,"median":27.050519,"eighty":58.147287,"marketCap":271358511},{"date":"2026-07-24","current":13.660897,"twenty":20.127155,"median":26.95251,"eighty":57.524987,"marketCap":254598133},{"date":"2026-07-31","current":14.21761,"twenty":20.033066,"median":26.893705,"eighty":56.881406,"marketCap":264973605},{"date":"2026-08-07","current":15.07415,"twenty":19.767151,"median":26.540872,"eighty":56.825443,"marketCap":241050726},{"date":"2026-08-14","current":15.123736,"twenty":19.424638,"median":26.403659,"eighty":56.657552,"marketCap":241843656},{"date":"2026-08-21","current":15.619596,"twenty":18.243689,"median":26.266446,"eighty":56.409541,"marketCap":249772956}],"updateTime":1787586724074},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NAGE\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660284429","title":"Niagen Bioscience Expands Tru Niagen Retail Distribution Through GNC, Sam’s Club Partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=2660284429","media":"Reuters","labels":["corporation","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660284429?lang=en_us&edition=fundamental","pubTime":"2026-08-20 20:34","pubTimestamp":1787229243,"startTime":"0","endTime":"0","summary":"Niagen Bioscience expands Tru Niagen retail distribution through GNC, Sam’s Club partnershipNiagen Bioscience expanded Tru Niagen distribution through new retail partnerships with GNC, Sam’s Club.Roll","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDL9fs47H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAGE","BK4121","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660226794","title":"NAGE Shines Spotlight on New NAD+ Skin‑Aging Trial as Cosmetic Demand Heats Up","url":"https://stock-news.laohu8.com/highlight/detail?id=2660226794","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660226794?lang=en_us&edition=fundamental","pubTime":"2026-08-20 00:30","pubTimestamp":1787157051,"startTime":"0","endTime":"0","summary":"Niagen Bioscience, Inc. ($NAGE) announced an update on their ongoing clinical study. Niagen Bioscience, Inc. (NAGE) is highlighting a new clinical ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nage-shines-spotlight-on-new-nad-skinaging-trial-as-cosmetic-demand-heats-up?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nage-shines-spotlight-on-new-nad-skinaging-trial-as-cosmetic-demand-heats-up?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","NAD","BK4183","NAGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658977988","title":"Niagen Bioscience to Present at Midwest IDEAS Investor Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2658977988","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658977988?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:33","pubTimestamp":1786537997,"startTime":"0","endTime":"0","summary":"Niagen Bioscience to Present at Midwest IDEAS Investor ConferenceNiagen Bioscience management will present at the Midwest IDEAS Investor Conference on Aug. 27, 2026 in Chicago.CFO Ozan Pamir is scheduled to speak from 2:40 p.m. to 3:15 p.m. CT.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Niagen Bioscience Inc. published the original content used to generate this news brief via Business Wire  on August 12, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDLh1pWG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","NAGE","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657160276","title":"Is Niagen Bioscience (NAGE) Quietly Recasting Its Brand Around E‑Commerce Scale And Clinical Proof","url":"https://stock-news.laohu8.com/highlight/detail?id=2657160276","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657160276?lang=en_us&edition=fundamental","pubTime":"2026-08-07 15:38","pubTimestamp":1786088325,"startTime":"0","endTime":"0","summary":"Niagen Bioscience recently announced that Tru Niagen®, a leading healthy-aging NAD+ supplement, became available on Walmart.com, expanding its reach through one of the United States’ largest digital retail platforms with initial 300 mg 30-count and 90-count offerings.\nA new peer-reviewed Aging Cell analysis linked Niagen’s nicotinamide riboside supplementation to reduced skeletal muscle epigenetic age acceleration, adding scientific weight to its healthy-aging positioning.\nNow we’ll examine...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/household/nasdaq-nage/niagen-bioscience/news/is-niagen-bioscience-nage-quietly-recasting-its-brand-around","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/household/nasdaq-nage/niagen-bioscience/news/is-niagen-bioscience-nage-quietly-recasting-its-brand-around","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["NAGE","BK4183","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657651269","title":"Niagen Bioscience CFO highlights telehealth as ‘high-expectation growth channel’","url":"https://stock-news.laohu8.com/highlight/detail?id=2657651269","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657651269?lang=en_us&edition=fundamental","pubTime":"2026-08-07 02:05","pubTimestamp":1786039556,"startTime":"0","endTime":"0","summary":"14:00 EDT Niagen Bioscience (NAGE) CFO highlights telehealth as ‘high-expectation growth channel’ Published first on TheFly – the ultimate source f...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/niagen-bioscience-cfo-highlights-telehealth-as-high-expectation-growth-channel-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/niagen-bioscience-cfo-highlights-telehealth-as-high-expectation-growth-channel-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HEAL","BMED","GDOC","LGHT","FDIF","BK4121","ANEW","EKG","CFO","NAGE","HTEC","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657512666","title":"Meet Niagen Bioscience: Fly exclusive interview with CFO Ozan Pamir","url":"https://stock-news.laohu8.com/highlight/detail?id=2657512666","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657512666?lang=en_us&edition=fundamental","pubTime":"2026-08-07 02:05","pubTimestamp":1786039540,"startTime":"0","endTime":"0","summary":"In an exclusive interview, Niagen Bioscience’s (NAGE) CFO Ozan Pamir spoke with The Fly about the company’s evolving NAD focused strategy, the stab...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/meet-niagen-bioscience-fly-exclusive-interview-with-cfo-ozan-pamir-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/meet-niagen-bioscience-fly-exclusive-interview-with-cfo-ozan-pamir-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NAGE","BK4183","BK4121","CFO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657947630","title":"Bananas, Bread, Bones…Walmart Seals Healthy Aging Deal With Niagen Bioscience","url":"https://stock-news.laohu8.com/highlight/detail?id=2657947630","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657947630?lang=en_us&edition=fundamental","pubTime":"2026-08-06 22:05","pubTimestamp":1786025145,"startTime":"0","endTime":"0","summary":"Walmart ($WMT) customers can now add something new to their shopping list of bananas, bread and beans – a healthy aging supplement from Niagen Bios...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/bananas-bread-bones-walmart-seals-healthy-ageing-deal-with-niagen-bioscience?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/bananas-bread-bones-walmart-seals-healthy-ageing-deal-with-niagen-bioscience?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1267930490.SGD","LU2087625088.SGD","LU1430594728.SGD","BK4533","LU0353189763.USD","NAGE","LU2360032135.SGD","BK4597","BK4534","BK4596","LU2430703251.USD","LU0289960550.SGD","LU2361045086.USD","LU1069347547.HKD","LU2265009873.SGD","BK4532","LU2592432038.USD","LU0310799852.SGD","IE0034235188.USD","LU1585245621.USD","LU1066051225.USD","LU2746668461.USD","TRUO","LU0256863902.USD","BK4581","BK4504","BK4121","LU0957791311.USD","LU2750360641.GBP","LU1035773651.USD","LU0640476718.USD","LU1066051811.HKD","LU0175139822.USD","LU1064131342.USD","IE000M9KFDE8.USD","LU2471134796.USD","UGE","BK4155","LU1674673691.USD","LU0553294199.USD","RTH","LU0353189680.USD","LU0265550359.USD","LU1815333072.USD","LU2097829019.USD","LU0545039389.USD","LU1988902786.USD","XLP","BK4585","LU1804176565.USD","BK4183","LU2471134879.HKD","LU2750360997.AUD","BK4588","LU2505996509.AUD","LU0949170772.SGD","LU1366192091.USD","LU2125154778.USD","LU1280957306.USD","LU0061474960.USD","LU0238689110.USD","LU0314104364.USD","LU2461242641.AUD","WMTI","LU2430703095.HKD","LU0417517546.SGD","LU2361044865.SGD","LU0149725797.USD","FSTA","LU2505996681.GBP","IE0001KFT4U8.USD","LU1116320737.USD","LU1066053197.SGD","LU1116320901.HKD","LU2361044949.HKD","LU2471134952.CNY","LU2430703178.SGD","LU0265550946.USD","LU0738911758.USD","LU0096362180.USD","LU0211327993.USD","LU2471134523.USD","WMT","LU2264538146.SGD","LU2381873111.SGD","LU0256863811.USD","LU1814569148.SGD","LU1778281490.HKD","LU2746668974.SGD","LU1003077747.HKD","BK4550","GB00BDT5M118.USD","LU0211328371.USD","LU2125154935.USD","HK0000819398.USD","LU1066051498.USD","LU1674673428.USD","LU0661504455.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657631154","title":"Niagen Bioscience announces Tru Niagen is now available at Walmart","url":"https://stock-news.laohu8.com/highlight/detail?id=2657631154","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657631154?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:42","pubTimestamp":1786020143,"startTime":"0","endTime":"0","summary":"Niagen Bioscience (NAGE) announced that Tru Niagen is now available at Walmart.com (WMT). “Expanding Tru Niagen’s availability on Walmart.com makes...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/niagen-bioscience-announces-tru-niagen-is-now-available-at-walmart-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/niagen-bioscience-announces-tru-niagen-is-now-available-at-walmart-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0553294199.USD","LU1804176565.USD","TRUO","LU2265009873.SGD","BK4581","BK4155","WMTI","RTH","LU0256863902.USD","BK4532","HK0000819398.USD","LU1035773651.USD","WMT","LU2505996681.GBP","IE0001KFT4U8.USD","LU0353189763.USD","LU0289960550.SGD","BK4121","LU1003077747.HKD","LU1066051498.USD","LU2746668974.SGD","LU0175139822.USD","BK4585","NAGE","LU2264538146.SGD","LU0265550946.USD","LU2125154778.USD","LU1585245621.USD","LU2461242641.AUD","LU2430703095.HKD","LU0238689110.USD","LU1430594728.SGD","BK4588","LU0957791311.USD","LU2361045086.USD","LU0949170772.SGD","BK4534","LU1280957306.USD","LU0417517546.SGD","LU1267930490.SGD","LU0211327993.USD","LU2361044949.HKD","LU2471134952.CNY","LU2097829019.USD","LU2361044865.SGD","GB00BDT5M118.USD","LU2505996509.AUD","LU1778281490.HKD","LU2087625088.SGD","IE000M9KFDE8.USD","LU1066051225.USD","LU2592432038.USD","LU0738911758.USD","LU2125154935.USD","UGE","LU0353189680.USD","LU1674673691.USD","BK4550","IE0034235188.USD","LU0149725797.USD","LU2430703251.USD","LU0265550359.USD","LU1069347547.HKD","LU0256863811.USD","LU2360032135.SGD","LU2471134796.USD","BK4596","LU0211328371.USD","LU0314104364.USD","LU1116320737.USD","LU2381873111.SGD","LU0061474960.USD","LU2471134523.USD","LU1116320901.HKD","LU0640476718.USD","LU2430703178.SGD","LU1066053197.SGD","BK4597","LU2746668461.USD","LU1674673428.USD","LU1814569148.SGD","FSTA","BK4183","LU1066051811.HKD","LU1366192091.USD","LU1815333072.USD","LU0545039389.USD","LU0661504455.SGD","LU2471134879.HKD","XLP","LU2750360997.AUD","LU0310799852.SGD","BK4504","BK4533","LU0096362180.USD","LU1988902786.USD","LU1064131342.USD","LU2750360641.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657205541","title":"Niagen Bioscience price target lowered to $10 from $12 at Roth Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2657205541","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657205541?lang=en_us&edition=fundamental","pubTime":"2026-08-05 19:50","pubTimestamp":1785930628,"startTime":"0","endTime":"0","summary":"Roth Capital lowered the firm’s price target on Niagen Bioscience (NAGE) to $10 from $12 and keeps a Buy rating on the shares. The company reported...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/niagen-bioscience-price-target-lowered-to-10-from-12-at-roth-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/niagen-bioscience-price-target-lowered-to-10-from-12-at-roth-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NAGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657856097","title":"Niagen Bioscience Posts Investor Presentation Focused on NAD+ Science and Healthy-Aging Products","url":"https://stock-news.laohu8.com/highlight/detail?id=2657856097","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657856097?lang=en_us&edition=fundamental","pubTime":"2026-08-05 05:50","pubTimestamp":1785880233,"startTime":"0","endTime":"0","summary":"Niagen Bioscience posts investor presentation focused on NAD+ science and healthy-aging productsNiagen Bioscience outlined a strategy centered on NAD+ science, led by its patented nicotinamide ribosid","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nNDL5wpNvx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","BK4183","NAGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657567398","title":"Niagen Bioscience Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657567398","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657567398?lang=en_us&edition=fundamental","pubTime":"2026-08-05 05:01","pubTimestamp":1785877299,"startTime":"0","endTime":"0","summary":"Niagen Bioscience Inc reports results for the quarter ended June 30 - Earnings SummaryNiagen Bioscience IncNAGE.OQreported quarterly adjusted earnings of 1 cent per share for the quarter ended June 30","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL8N44134C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","NAGE","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657056978","title":"Niagen Bioscience Q2 Net Sales Fall, Missing Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2657056978","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657056978?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:09","pubTimestamp":1785874173,"startTime":"0","endTime":"0","summary":"Niagen Bioscience Q2 net sales fall, missing estimatesOverviewU.S. bioscience firm's Q2 net sales declined and missed analyst expectationsQ2 net income was $1.0 mln, down from $3.6 mln a year earlierC","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL1N44113L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","LPCN","BK4007","BK4139","PVLA","NAGE","STOK","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657156931","title":"Niagen Bioscience Q2 EPS $0.01 Misses $0.02 Estimate, Sales $29.785M Miss $30.690M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2657156931","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657156931?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:03","pubTimestamp":1785873790,"startTime":"0","endTime":"0","summary":"Niagen Bioscience (NASDAQ:NAGE) reported quarterly earnings of $0.01 per share which missed the analyst consensus estimate of $0.02 by 50 percent. This is a 75 percent decrease over earnings of $0.04 per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/60927888/niagen-bioscience-q2-eps-0-01-misses-0-02-estimate-sales-29-785m-miss-30-690m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Niagen Bioscience Q2 EPS $0.01 Misses $0.02 Estimate, Sales $29.785M Miss $30.690M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657756158","title":"Niagen Bioscience: Ingredient Business Expected to be Lower than Prior Year as Some Commercial Partners Continue to Face More Competitive Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2657756158","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657756158?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:02","pubTimestamp":1785873721,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nPLXTMZR6V:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4183","NAGE","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657619355","title":"Niagen Bioscience: Expect Niagen Plus Growth & New Skincare Partnerships to Become Meaningful Contributors Beginning 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2657619355","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657619355?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:02","pubTimestamp":1785873721,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nPLXTMZR6V:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","BK4183","NAGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657569864","title":"Niagen Bioscience Inc Q2 Net Income USD 963 Thousand","url":"https://stock-news.laohu8.com/highlight/detail?id=2657569864","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657569864?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:02","pubTimestamp":1785873721,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nPLXTMZR6V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4183","BK4121","NAGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657028569","title":"Niagen Bioscience Inc Q2 EPS USD 0.01 VS. Ibes Estimate USD 0.01","url":"https://stock-news.laohu8.com/highlight/detail?id=2657028569","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657028569?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:02","pubTimestamp":1785873721,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nPLXTMZR6V:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","BK4183","NAGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657698875","title":"Niagen Bioscience, Inc. Reports Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2657698875","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657698875?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:02","pubTimestamp":1785873720,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nTUA42RMYR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","BK4183","NAGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656794493","title":"Niagen Bioscience Taps Evotec to Advance Preclinical Development of Nb4168 Rare-Disease Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2656794493","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656794493?lang=en_us&edition=fundamental","pubTime":"2026-08-03 20:33","pubTimestamp":1785760393,"startTime":"0","endTime":"0","summary":"Niagen Bioscience taps Evotec to advance preclinical development of NB4168 rare-disease candidateNiagen Bioscience selected Evotec as a contract research partner to advance preclinical development of ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDL4wjyhJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","BK4183","NAGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656379108","title":"Niagen Bioscience - Plans Ind Application to FDA for Nb4168","url":"https://stock-news.laohu8.com/highlight/detail?id=2656379108","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656379108?lang=en_us&edition=fundamental","pubTime":"2026-08-03 20:33","pubTimestamp":1785760382,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nFWN44019B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","BK4183","NAGE"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":116,"code":"91000000","status":"200"}]}}